Senate confirms Makary as FDA chief with agency cuts, return-to-office in force

Zachary Brennan

Senior Editor

The Senate on Tuesday voted 56-44 to confirm Johns Hopkins researcher Marty Makary as FDA commissioner, putting him in charge of the agency amid ongoing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Senate confirms Makary as FDA chief with agency cuts, return-to-office in force

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

FDA's Peter Marks resigns, saying he won't accept Kennedy's 'misinformation and lies'

Bluebird gets new M&A bid, seeking to top private equity offer

Small biotech joins list of health companies taking a trip to Trump's Mar-a-Lago

Novo Nordisk pays $200M upfront for China-based biotech’s triple-G obesity shot

‘People will die’: End of NIH grants guts work between academics and companies to counter next pandemic

European regulator rejects Lilly's Alzheimer’s drug over potentially fatal side effects

Sen­ate con­firms Makary as FDA chief with agency cuts, re­turn-to-of­fice in force

Senior Editor

Sign up to read this article for free.

more like this

Gondolabio

Palo Alto, CA, USA

Senate confirms Makary as FDA chief with agency cuts, return-to-office in force